Cargando…
Shared decision making of burdensome surveillance tests using personalized schedules and their burden and benefit
Benchmark surveillance tests for detecting disease progression (eg, biopsies, endoscopies) in early‐stage chronic noncommunicable diseases (eg, cancer, lung diseases) are usually burdensome. For detecting progression timely, patients undergo invasive tests planned in a fixed one‐size‐fits‐all manner...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305929/ https://www.ncbi.nlm.nih.gov/pubmed/35146793 http://dx.doi.org/10.1002/sim.9347 |